Balaji Amines Concall was today at 4:00 PM.

Here are key highlights of the Conference Call😀

@drprashantmish6 @punitbansal14
Updates:

-Demand for products like Acetonitrile, DMF, NEP, DMA and TEA elevated as they are intermediates for drugs required for COVID-19 treatment
-Ramp up the production of Acetonitrile to 18-20T per day
-Receive award for export
-Subsidiary performance improved
-Demand for methyl amine increased. Separate plant for Methylamines with installed capacity of 48,000 TPA and 80% of capacity is captively used
-CAPEX of 105 crore completed and expected to commission production of Acetonitrile
-Inventory maintaining for only a month and there wont be any problem
-No change in Amonia price
-Acetonitrile price: 250-280 prices and there has been no major change
DMF:

-India has short supply in this
-Antidumping duty might increase the price of product
-However without antidumping there is increasing demand of product
-Filed for expansion capacity of 30,000 TPA
-DMF prices are already increasing.
-From 60Rs to 90Rs as of now. While with the ADD, price support of 80Rs is expected by management
-Expect to reach 1800-2000 TPA till end of FY 2021
-Breakeven for DMF at price was increased with the increase in RM & end product price
Balaji Specialty:

-Sales 55 cr. Currently in Cash loss, expect from next quarter to have cash profit
-Order book of subsidy is slowly increasing & of small amt. Mainly sales are not upfront.
DMF, Methylamines & other products will be in line commercialized having EC in route
Morpholine

-Demand of Morpholine in export market is increasing
-Sales to China has been made in last quarter
-With current market situation, company can easily compete with global players
-In case of price decrease of RM, mgnt has to decrease price of product as well
Loss in CFL:

-Worth of inventory is 7-8 crores. While there would be loss in sale of inventory
-Land 1.6 crores. Building 6.6 Crores. revaluation will make this 20-25 crores.
Balaji specialty is a new company. Going to big company of specialty would not allow the subsidiary to gain big order because of small balance sheet. Hence acquired

Methylamines is expected to be commercialized till June 2022 with capacity of 48,000 TPA
Squeeze of supply of DMF led to increase in demand of DMF in short term

Month on month growth has been started.
Major customer include Coromandal. However management doesn't want a big order due to fluctuation of RM prices
Refer to our Q2 FY 2021 conference call here 👇👇👇

thetycoonmindset.com/conference-cal…

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with The Tycoon Mindset

The Tycoon Mindset Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @tycoonmindset05

3 Nov
Neuland Laboratories Concall was today at 5:00 PM.

Here are key highlights of the Conference Call 😀

@unseenvalue @drprashantmish6 @AdityaKhemka5 @punitbansal14
Business Updates:
• GDS and CMS segment both have contribute well.
• Unit 3 will be commercialized in 2 quarter of FY 2021
• Growth was led by Levofloxacin and Levetiracetam
• CMS business was the key driver for growth. Good progress from CMS
CAPEX:
• Expectation of 90cr this year and 60-70cr is done
• No further updates on CAPEX but there will be need

CMS:
• Growth driven by increase in commercial projects which done well. Baseline project done well
• CMS business could be volatile. Overall growth is positive
Read 20 tweets
3 Nov
Coromandel International Concall was today at 2:30 PM.

Here are key highlights of the Conference Call😀
- Rural economy is at a good spot it and had a bumper harvest in Kharif season.

- Above normal rainfall happened. Reservoir level is good. Main crops like cotton had harvest of106% and rice had the harvest of 102%.
- Government policies: Government is proactively making reforms in agriculture.

- There is focus on making better storage facility, infrastructure and better access for farmers to markets.

- There has been increase in MSP.
Read 20 tweets
3 Nov
Thyrocare Technologies Concall was today at 12:00 PM.

Here are key highlights of the Conference Call 😀

@amitgupta0310 @MarketScientist @MashraniVivek
Business Updates:

• EBIDTA margins improved, significant growth from COVID.
• Non - Covid business is back to pre-covid levels.

COVID test:
• RTPCR tests in Q2 ~ 2.7 Lac
• Antibody tests reported in Q2
• Pathology Volumes increased by 83% in Q2
• Added manpower in the operational end
• In Q2 almost 40% of the business is from Covid
• As the industry open up, there can be more demand of antibody test.
• There would be no complexity in serving the operational aspect of working with open up in the economy
Read 16 tweets
2 Nov
Edelweiss Concall was today at 4:00 pm

Here are the Key highlights of the Conference Call 😀

@iRadhikaGupta @_soniashenoy @Moneylifers @rasheshshah @Amit_Jeswani1
- 2020 has been a year of Reset.
- Recently, economy is going through a gradual phase of recovery.
- Q2 has been as per planned
- 4 major focus
1. Progress made in the focus areas
2. Strengthening of balance sheet
3. Update on growth and business
4. Sustainability and environment
Progress on focus areas.
- Continue to focus on liquidity and equity.
- Debt to equity ratio has come down to 3.1 from 5
- Total borrowing have come down to 30k cr. from 50k cr. in 2 years
- 2k cr. would be received from PAG deal, which will make the company capital surplus
Read 26 tweets
2 Nov
Cadila Healthcare Concall was today at 6:15 PM.

Here are key highlights of the Conference Call😀
-Human health and consumer wellness business has seen improvement and is expected to grow in coming quarters.

-Animal health care segment grew by double digit in YoY basis.

- 40% reduction in Net debt as compared to March 2020
- Generics business grew because of Volume expansion.

- Pharmaceutical segment in India: Human health formulation is up 11% in YoY basis.
Read 19 tweets
2 Nov
Quess Corp Ltd Concall was today at 12:00 PM.

Here are highlights of the Conference Call 😀

@drprashantmish6 @amitmantri @safiranand
Business Updates:
• 90-180 days economy was closed.
• Headcount was 384000, and reached to 314000 and in Q1 reached to 324000. Headcount now remaining stable.
• Vedang is still partially closed
• Improvement of business from the month of july and september
Cost Reduction: 70 crores of cost has been reduced to 53 crores which will be permanent saving of 17 crores unless increase in sudden cost

Debt Reduction:
Debt reduction 1147 cr and now the gross debt level is 624 crore.
Net debt reduced from 254 to 45 crores debt on qoq basis
Read 22 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!